Person: MİRİOĞLU, ŞAFAK
13 results
Search Results
Now showing 1 - 10 of 13
Publication Metadata only Konjenital Böbrek ve/veya Üriner Anomalisi Olan Hastalarda Renal Transplantasyon Sonuçları(2021-10-13T00:00:00Z) Oto, Özgür Akın; Mirioğlu, Şafak; Yazıcı, Halil; Dirim, Ahmet Burak; Güller, Nurane; Şafak, Seda; Demir, Erol; Artan, Ayşe Serra; Özlük, Mesude Yasemin; Çalışkan, Yaşar; Türkmen, Aydın; MİRİOĞLU, ŞAFAKPublication Metadata only Kidney Transplantation in Patients with Hereditary Kidney Diseases(2021-06-04T00:00:00Z) Çalışkan, Yaşar; Güller, Nurane; Dirim, Ahmet Burak; Şafak, Seda; Mirioğlu, Şafak; Yazıcı, Halil; Yıldız, Abdulmecit; Oto, Özgür Akın; Demir, Erol; Özlük, Mesude Yasemin; Türkmen, Aydın; Lentıne, Krista; MİRİOĞLU, ŞAFAKPublication Metadata only Oxidative stress and macrophage infiltration in IgA nephropathy.(2021-11-16T00:00:00Z) Çalışkan, Yaşar; Demir, Erol; Karatay, Ecem; Özlük, Mesude Yasemin; Mirioğlu, Şafak; Dirim, Ahmet Burak; Artan, Ayşe Serra; Usta Akgül, Sebahat; Oto, Özgür Akın; Savran Oğuz, Fatma; Türkmen, Aydın; Lentıne, Krista L.; Yazıcı, Halil; MİRİOĞLU, ŞAFAKPublication Metadata only Fibriler Glomerülonefrit Ayırıcı Tanısında DNAJB9 Ekspresyonu ve Atipik Formlar(2021-05-20T00:00:00Z) Özlük, Mesude Yasemin; Bağbudar, Sidar; Karaoğlan Yıldırım, Çağla Şafak; Demir, Erol; Mirioğlu, Şafak; Cebeci, Egemen; Başhan, Yağmur; Uzun, Büşra; Yazıcı, Halil; Hürdoğan, Özge; Solakoğlu, Seyhun; Kılıçaslan, Işın; MİRİOĞLU, ŞAFAKPublication Metadata only Lower baseline eGFR levels and IgA nephropathy prediction tool.(2021-08-01T00:00:00Z) Artan, Ayşe Serra; Mirioğlu, Şafak; Demir, Erol; Dirim, Ahmet Burak; Şafak, Seda; Garayeva, Nurana; Özlük, Mesude Yasemin; Oto, Özgür Akın; Yazıcı, Halil; Çalışkan, Yaşar; MİRİOĞLU, ŞAFAKPublication Metadata only Böbrek nakli alıcılarında LIMS1 genotiplerinin rejeksiyon riskiyle ilişkisi(2020-10-15T00:00:00Z) Mirioğlu, Şafak; Çalışkan, Yaşar Kerem; Özlük, Mesude Yasemin; Dirim, Ahmet Burak; Gürel, Erdem; Demir, Erol; Oto, Özgür Akın; Kazancıoğlu, Rümeyza; Kılıçaslan, Işın; Oğuz, Fatma; Yazıcı, Halil; Türkmen, Aydın; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZAPublication Metadata only Böbrek naklinde alıcı ve donör LIMS1 uyumsuzluğunun rejeksiyonla ilişkisi(2020-10-15T00:00:00Z) Mirioğlu, Şafak; Çalışkan, Yaşar Kerem; Özlük, Mesude Yasemin; Dirim, Ahmet Burak; Aksoy, Elif; Demir, Erol; Oto, Özgür Akın; Kazancıoğlu, Rümeyza; Kılıçaslan, Işın; Oğuz, Fatma; Yazıcı, Halil; Türkmen, Aydın; MİRİOĞLU, ŞAFAK; KAZANCIOĞLU, RÜMEYZAPublication Metadata only The importance of glomerular C3 accumulation in elderly patients with primary membranous nephropathy(2022-05-01T00:00:00Z) Oto, Özgür Akın; Mirioğlu, Şafak; Dirim, Ahmet Burak; Şafak, Seda; Güller, Nurana; Demir, Erol; Artan, Ayşe Serra; Özlük, Mesude Yasemin; Uçar, Ali Rıza; Soltanova, Lala; Nuriyev, Kanan; Yazıcı, Halil; Çalışkan, Yaşar Kerem; MİRİOĞLU, ŞAFAKPublication Metadata only Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus(2021-11-06T00:00:00Z) Mirioğlu, Şafak; Çınar, Suzan; Uludağ, Ömer; Gürel, Erdem; Varelci, Sibel; Özlük, Mesude Yasemin; Kılıçaslan, Işın; Yalçınkaya, Yasemin; Yazıcı, Halil; Gül, Ahmet; İnanç, Murat; Artım Esen, Bahar; MİRİOĞLU, ŞAFAKPublication Metadata only LIMS1 Risk Genotype and T-Cell Mediated Rejection in Kidney Transplant Recipients.(2021-04-28T00:00:00Z) Çalışkan, Yaşar; Karahan, Gonca; Usta Akgül, Sebahat; Mirioğlu, Şafak; Özlük, Mesude Yasemin; Yazıcı, Halil; Demir, Erol; Dirim, Ahmet Burak; Türkmen, Aydın; Edwards, John; Oğuz Savran, Fatma; Sever, Mehmet Şükrü; Kiryluk, Krzysztof; Gharavi, Ali; Lentine, Krista L; MİRİOĞLU, ŞAFAKBackground:This study aims to examine the association of LIM Zinc Finger Domain Containing 1 (LIMS1) genotype with allograft rejection in an independent kidney transplant cohort.Methods:We genotyped 841 kidney transplant recipients for LIMS1 rs893403 variant by Sanger sequencing followed by PCR confirmation of the deletion. Recipients who were homozygous for LIMS1 rs893403 genotype GG were compared to AA/AG genotypes. The primary outcome was T-cell mediated (TCMR) or antibody mediated rejection (ABMR) and secondary outcome was allograft loss.Results:After a median follow-up of 11.4 years, the rate of TCMR was higher in recipients with the GG (n = 200) compared to AA/AG (n = 641) genotypes [25 (12.5%) vs 35 (5.5%); p = 0.001] while ABMR did not differ by genotype [18 (9.0%) vs 62 (9.7%)]. Recipients with GG genotype had 2.4-times higher risk of TCMR than those who did not have this genotype (adjusted hazard ratio (aHR), 1.442.434.12, p = 0.001). A total of 189 (22.5%) recipients lost their allografts during follow up. Kaplan-Meier estimates of 5-year (94.3% vs. 94.4%, p = 0.99) and 10-year graft survival rates (86.9% vs. 83.4%, p = 0.31) did not differ significantly in those with GG compared to AA/AG groups.Conclusions:Our study demonstrates that recipient LIMS1 risk genotype is associated with increased risk of TCMR after kidney transplantation, confirming the role of LIMS1 locus in allograft rejection. These findings may have clinical implications for the prediction and clinical management of kidney transplant rejection by pretransplant genetic testing of recipients and donors for LIMS1 risk genotype.